Molecular Diagnostics Market Size to Reach US$ 33.7 Billion by 2032 | IMARC Group
The latest report by IMARC Group, titled “Molecular Diagnostics Market Report by Product (Reagents and Kits, Instruments, Software and Services), Technology (Polymerase Chain Reactions (PCR), Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), and Others), Application (Infectious Diseases Diagnostics, Oncology, Genetic Testing, Blood Screening, and Others), End Users (Hospitals, Laboratories, and Others), and Region 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on the market.
The global molecular diagnostics market size reached US$ 19.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032.
Top 13 Companies in the Molecular Diagnostics Industry:
- Abbott Laboratories
- Agilent Technologies Inc.
- Becton Dickinson and Company
- Biomerieux SA
- Danaher Corporation
- Diasorin Molecular LLC (DiaSorin)
- F. Hoffmann-La Roche AG (Roche Holding AG)
- Hologic Inc.
- Illumina Inc.
- Myriad Genetics Inc.
- Qiagen
- Quidel Corporation
- Thermo Fisher Scientific
Factors Driving Growth in the Molecular Diagnostics Industry:
- Technological Advancements in Molecular Diagnostics:
Continuous technological advancements and innovations aimed at improving the accuracy, efficiency, and speed of diagnostic tests are pivotal in bolstering market growth. The development of next-generation sequencing (NGS) for rapid sequencing of large DNA strands and advancements in polymerase chain reaction (PCR) techniques, such as real-time and digital PCR, are key growth-inducing factors. These advancements enable comprehensive genomic profiling and improved detection and quantification of DNA and RNA, ultimately paving the way for the development of faster point-of-care (POC) molecular diagnostic tests, which enhance patient outcomes.
- Increasing Prevalence of Infectious Diseases and Cancer:
The heightened global incidence of infectious diseases and cancer significantly drives market growth. The rise in infectious diseases like hepatitis, tuberculosis, and HIV underscores the urgent need for robust and rapid diagnostic solutions, facilitating early disease detection, timely treatment, and prevention of outbreaks. Additionally, the increasing prevalence of cancer fuels demand for molecular diagnostics in oncology, particularly for identifying genetic mutations and biomarkers associated with various cancer types, further propelling the market forward.
- Rise in Personalized Medicine and Healthcare Customization:
The ongoing shift towards personalized medicine and healthcare customization, focusing on tailoring medical treatment to individual characteristics, is a critical support for market growth. The utilization of molecular diagnostics to provide essential data for implementing personalized medicine strategies enables healthcare providers to predict disease risk, select optimal therapies, and monitor treatment responses based on a patient's genetic profile. This aligns with the heightened demand for personalized healthcare solutions among patients and providers, driving investment and innovation in molecular diagnostics to fuel market expansion.
For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/molecular-diagnostics-market/requestsample
Molecular Diagnostics Market Report Segmentation:
By Product:
- Reagents and Kits
- Instruments
- Software and Services
Reagents and kits hold the largest market share as they are essential consumables that are required for performing a wide range of molecular diagnostic procedures.
By Technology:
- Polymerase Chain Reactions (PCR)
- Hybridization
- DNA Sequencing
- Microarray
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Others
Polymerase chain reactions (PCR) accounted for the largest market share due to its sensitivity, specificity, and ability to rapidly amplify small quantities of DNA.
By Application:
- Infectious Diseases Diagnostics
- Oncology
- Genetic Testing
- Blood Screening
- Others
Infectious diseases diagnostics represented the largest segment due to the rising prevalence of infectious diseases, coupled with the need for rapid and accurate diagnostic solutions.
By End Users:
- Hospitals
- Laboratories
- Others
On the basis of end users, the market has been divided into hospitals, laboratories, and others.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America's dominance in the molecular diagnostics market is attributed to its advanced healthcare infrastructure, high adoption of advanced diagnostic technologies, significant healthcare spending, and the presence of key market players in the region.
Global Molecular Diagnostics Market Trends:
- Integration of Digital and Cloud-based Technologies: The integration of digital and cloud-based technologies supports the storage of genetic data, enabling advanced computational analyses and contributing to market growth.
- Emphasis on Big Data Analytics and AI Integration: Big data analytics, along with the integration of artificial intelligence (AI) and machine learning (ML) algorithms, enhances diagnostic accuracy and predictive capabilities, fostering market expansion.
- Expansion of Telemedicine and Remote Diagnostics: The widespread expansion of telemedicine and remote diagnostics, driven by the need for accessible healthcare solutions, leverages mobile health technologies and portable diagnostic devices, enabling self-sampling and remote monitoring of chronic conditions, thereby catalyzing market growth.
Browse the Full Report with TOC & List of Figures: https://www.imarcgroup.com/molecular-diagnostics-market
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Comments
Post a Comment